Breast Cancer Clinical Trial

Clinical Trial Finder Breast Cancer Trials

Pycnogenol for the Treatment of Lymphedema

See Locations Near You

Summary

The objectives of this study are to evaluate the effectiveness of Pycnogenol (French maritime pine bark extract) for arm lymphedema in women following treatment for breast cancer, to evaluate the accuracy and sensitivity of bioelectric impedence as a measurement of lymphedema of the arm, and to validate the proposed arm lymphedema quality-of-life questionnaire.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

> 6 months from last surgical and/or radiation treatment to the affected axilla
Unilateral lymphedema of the upper extremity

Exclusion Criteria:

May not be receiving or be scheduled to receive cytotoxic or radiation chemotherapy treatment while on this study

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

2

Study ID:

NCT00214032

Recruitment Status:

Completed

Sponsor:

University of Wisconsin, Madison

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University of Wisconsin
Madison Wisconsin, 53792, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 2

Estimated Enrollment:

2

Study ID:

NCT00214032

Recruitment Status:

Completed

Sponsor:


University of Wisconsin, Madison

How clear is this clinincal trial information?

Clinical Trial Resources

SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials for Breast Cancer
Have You Been Diagnosed With Late-Stage Breast Cancer? Know That You Have Treatment Options.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider